|
2025-03-19 |
2025-03-17 |
PS
Planned sale
|
Waddill William D.
Non-Executive Director
|
4,000
-23.4%
54.25
USD 217,000
|
4,000
-23.4%
|
54.25
|
USD 217,000
|
|
|
2025-03-14 |
2025-03-13 |
S
Sale
|
MOLINA ARTURO MD
Chief Medical Officer
Officer
|
30,514
-26.7%
55.74
USD 1,700,850
|
30,514
-26.7%
|
55.74
|
USD 1,700,850
|
|
|
2025-03-14 |
2025-03-12 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
24,903
-28.4%
58.73
USD 1,462,553
|
24,903
-28.4%
|
58.73
|
USD 1,462,553
|
|
|
2025-02-20 |
2025-02-19 |
S
Sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
5,359
-1.0%
38.18
USD 204,607
|
5,359
-1.0%
|
38.18
|
USD 204,607
|
|
|
2024-11-27 |
2024-11-27 |
S
Sale
|
MOLINA ARTURO MD
Chief Medical Officer
Officer
|
16,000
-25.6%
44.83
USD 717,280
|
16,000
-25.6%
|
44.83
|
USD 717,280
|
|
|
2024-11-27 |
2024-11-27 |
S
Sale
|
MOLINA ARTURO MD
Chief Medical Officer
Officer
|
10,000
-17.7%
44.50
USD 445,000
|
10,000
-17.7%
|
44.50
|
USD 445,000
|
|
|
2024-11-27 |
2024-11-26 |
S
Sale
|
MOLINA ARTURO MD
Chief Medical Officer
Officer
|
5,529
-10.6%
45.60
USD 252,122
|
5,529
-10.6%
|
45.60
|
USD 252,122
|
|
|
2024-11-27 |
2024-11-26 |
S
Sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
21,480
-5.0%
46.25
USD 993,450
|
21,480
-5.0%
|
46.25
|
USD 993,450
|
|
|
2024-11-27 |
2024-11-26 |
S
Sale
|
Gupta Suneel
Chief Development Officer
Officer
|
19,191
-6.7%
45.50
USD 873,191
|
19,191
-6.7%
|
45.50
|
USD 873,191
|
|
|
2024-11-27 |
2024-11-25 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
78,520
-15.3%
46.96
USD 3,687,299
|
78,520
-15.3%
|
46.96
|
USD 3,687,299
|
|
|
2024-11-27 |
2024-11-25 |
S
Sale
|
Gupta Suneel
Chief Development Officer
Officer
|
103,437
-28.8%
46.04
USD 4,762,239
|
103,437
-28.8%
|
46.04
|
USD 4,762,239
|
|
|
2024-11-19 |
2024-11-15 |
S
Sale
|
MOLINA ARTURO MD
Chief Medical Officer
Officer
|
1,906
-3.9%
40.98
USD 78,108
|
1,906
-3.9%
|
40.98
|
USD 78,108
|
|
|
2024-09-13 |
2024-09-11 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
12,000
-25.6%
44.47
USD 533,640
|
12,000
-25.6%
|
44.47
|
USD 533,640
|
|
|
2024-09-13 |
2024-09-11 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
2,203
-5.9%
44.59
USD 98,232
|
2,203
-5.9%
|
44.59
|
USD 98,232
|
|
|
2024-09-12 |
2024-09-10 |
PS
Planned sale
|
Waddill William D.
Non-Executive Director
|
8,000
-40.0%
45.00
USD 360,000
|
8,000
-40.0%
|
45.00
|
USD 360,000
|
|
|
2024-07-26 |
2024-07-24 |
PS
Planned sale
|
Waddill William D.
Non-Executive Director
|
8,000
-40.0%
40.00
USD 320,000
|
8,000
-40.0%
|
40.00
|
USD 320,000
|
|
|
2024-06-11 |
2024-06-07 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
35,000
-6.4%
35.19
USD 1,231,650
|
35,000
-6.4%
|
35.19
|
USD 1,231,650
|
|
|
2024-06-11 |
2024-06-07 |
PS
Planned sale
|
Waddill William D.
Non-Executive Director
|
8,000
-40.0%
35.00
USD 280,000
|
8,000
-40.0%
|
35.00
|
USD 280,000
|
|
|
2024-04-19 |
2024-04-18 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
1,234
-3.2%
25.11
USD 30,986
|
1,234
-3.2%
|
25.11
|
USD 30,986
|
|
|
2024-04-02 |
2024-04-01 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
25,000
-4.4%
28.31
USD 707,750
|
25,000
-4.4%
|
28.31
|
USD 707,750
|
|
|
2024-03-01 |
2024-03-01 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
2,248
-5.5%
32.33
USD 72,678
|
2,248
-5.5%
|
32.33
|
USD 72,678
|
|
|
2024-03-01 |
2024-03-01 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
12,000
-22.8%
32.22
USD 386,640
|
12,000
-22.8%
|
32.22
|
USD 386,640
|
|
|
2024-03-01 |
2024-03-01 |
PS
Planned sale
|
Waddill William D.
Non-Executive Director
|
12,975
-52.0%
31.34
USD 406,637
|
12,975
-52.0%
|
31.34
|
USD 406,637
|
|
|
2024-03-01 |
2024-03-01 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
30,000
-5.0%
31.62
USD 948,600
|
30,000
-5.0%
|
31.62
|
USD 948,600
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
2,089
-4.9%
31.00
USD 64,759
|
2,089
-4.9%
|
31.00
|
USD 64,759
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
Ali Asif
Chief Financial Officer
Officer
|
7,850
-15.5%
30.61
USD 240,289
|
7,850
-15.5%
|
30.61
|
USD 240,289
|
|
|
2024-01-11 |
2024-01-09 |
PS
Planned sale
|
Gupta Suneel
Chief Development Officer
Officer
|
5,000
-2.6%
25.00
USD 125,000
|
5,000
-2.6%
|
25.00
|
USD 125,000
|
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
75,000
-12.3%
20.08
USD 1,506,000
|
75,000
-12.3%
|
20.08
|
USD 1,506,000
|
|
|
2024-01-04 |
2023-11-15 |
S
Sale
|
MOLINA ARTURO MD
Chief Medical Officer
Officer
|
1,848
-7.6%
16.24
USD 30,012
|
1,848
-7.6%
|
16.24
|
USD 30,012
|
|
|
2021-12-23 |
2021-12-21 |
S
Sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
15,000
-3.0%
32.14
USD 482,171
|
15,000
-3.0%
|
32.14
|
USD 482,171
|
|
|
2021-02-12 |
2021-02-11 |
PS
Planned sale
|
Noonberg Sarah B.
Non-Executive Director
|
3,700
-100.0%
25.09
USD 92,833
|
3,700
-100.0%
|
25.09
|
USD 92,833
|
|
|
2021-02-12 |
2021-02-10 |
PS
Planned sale
|
Noonberg Sarah B.
Non-Executive Director
|
400
-100.0%
26.04
USD 10,416
|
400
-100.0%
|
26.04
|
USD 10,416
|
|
|
2021-02-12 |
2021-02-10 |
PS
Planned sale
|
Noonberg Sarah B.
Non-Executive Director
|
4,300
-91.5%
25.42
USD 109,306
|
4,300
-91.5%
|
25.42
|
USD 109,306
|
|
|
2021-01-20 |
2021-01-19 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
24,846
-5.5%
24.60
USD 611,105
|
24,846
-5.5%
|
24.60
|
USD 611,105
|
|
|
2020-08-12 |
2020-08-11 |
PS
Planned sale
|
KHOSLA CHAITAN PHD
Non-Executive Director
|
2,499
-100.0%
17.19
USD 42,952
|
2,499
-100.0%
|
17.19
|
USD 42,952
|
|
|
2020-03-12 |
2020-03-12 |
B
Purchase
|
SELICK HAROLD E
Non-Executive Director
|
12,000
+362.5%
6.70
USD 80,400
|
12,000
+362.5%
|
6.70
|
USD 80,400
|
|
|
2019-12-03 |
2019-12-03 |
B
Purchase
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
20,000
+5.1%
5.65
USD 113,000
|
20,000
+5.1%
|
5.65
|
USD 113,000
|
|
|
2019-12-03 |
2019-12-03 |
B
Purchase
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
10,000
+2.6%
5.55
USD 55,500
|
10,000
+2.6%
|
5.55
|
USD 55,500
|
|
|
2019-12-03 |
2019-12-03 |
B
Purchase
|
Giraudo Bryan
Non-Executive Director
|
8,000
+inf%
5.70
USD 45,620
|
8,000
+inf%
|
5.70
|
USD 45,620
|
|
|
2019-12-03 |
2019-12-03 |
PP
Planned purchase
|
Gupta Suneel
EVP Clinical Operations
Officer
|
30,000
+153.8%
5.13
USD 153,900
|
30,000
+153.8%
|
5.13
|
USD 153,900
|
|
|
2019-12-03 |
2019-12-03 |
B
Purchase
|
Kalkofen Donald A.
Chief Financial Officer
Officer
|
562
+91.7%
5.09
USD 2,861
|
562
+91.7%
|
5.09
|
USD 2,861
|
|
|
2019-12-03 |
2019-12-03 |
B
Purchase
|
Kalkofen Donald A.
Chief Financial Officer
Officer
|
613
+inf%
5.10
USD 3,126
|
613
+inf%
|
5.10
|
USD 3,126
|
|
|
2019-08-08 |
2019-08-06 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
10,792
-2.8%
8.85
USD 95,535
|
10,792
-2.8%
|
8.85
|
USD 95,535
|
|
|
2019-08-08 |
2019-08-06 |
PS
Planned sale
|
Liu David Y
Chief Scientific Officer
Officer
|
3,395
-6.4%
8.85
USD 30,044
|
3,395
-6.4%
|
8.85
|
USD 30,044
|
|
|
2019-03-04 |
2019-03-01 |
S
Sale
|
Liu David Y
Chief Scientific Officer
|
810
-1.6%
8.03
USD 6,504
|
810
-1.6%
|
8.03
|
USD 6,504
|
|
|
2019-03-04 |
2019-03-01 |
S
Sale
|
Shames Richard S.
Chief Medical Officer
|
657
-2.0%
8.03
USD 5,276
|
657
-2.0%
|
8.03
|
USD 5,276
|
|
|
2019-03-04 |
2019-03-01 |
S
Sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
2,183
-0.6%
8.03
USD 17,529
|
2,183
-0.6%
|
8.03
|
USD 17,529
|
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
Shames Richard S.
Chief Medical Officer
Officer
|
2,580
-9.6%
7.71
USD 19,892
|
2,580
-9.6%
|
7.71
|
USD 19,892
|
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
Shames Richard S.
Chief Medical Officer
Officer
|
198
-0.7%
8.15
USD 1,614
|
198
-0.7%
|
8.15
|
USD 1,614
|
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
Liu David Y
Chief Scientific Officer
Officer
|
3,821
-9.4%
7.74
USD 29,562
|
3,821
-9.4%
|
7.74
|
USD 29,562
|
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
10,132
-2.8%
7.71
USD 78,118
|
10,132
-2.8%
|
7.71
|
USD 78,118
|
|
|
2019-02-08 |
2019-02-06 |
S
Sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
777
-0.2%
8.10
USD 6,292
|
777
-0.2%
|
8.10
|
USD 6,292
|
|
|
2018-05-21 |
2018-05-17 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
38,968
-1.8%
6.09
USD 237,358
|
38,968
-1.8%
|
6.09
|
USD 237,358
|
|
|
2018-05-16 |
2018-05-16 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
29,441
-1.3%
6.46
USD 190,071
|
29,441
-1.3%
|
6.46
|
USD 190,071
|
|
|
2018-05-16 |
2018-05-15 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
57,715
-2.6%
6.48
USD 374,080
|
57,715
-2.6%
|
6.48
|
USD 374,080
|
|
|
2018-05-16 |
2018-05-14 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
77,591
-3.3%
6.37
USD 494,224
|
77,591
-3.3%
|
6.37
|
USD 494,224
|
|
|
2018-03-26 |
2018-03-23 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
59,950
-2.5%
20.71
USD 1,241,325
|
59,950
-2.5%
|
20.71
|
USD 1,241,325
|
|
|
2018-03-22 |
2018-03-22 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
4,759
-0.2%
20.62
USD 98,133
|
4,759
-0.2%
|
20.62
|
USD 98,133
|
|
|
2018-03-22 |
2018-03-21 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
17,699
-0.7%
20.61
USD 364,727
|
17,699
-0.7%
|
20.61
|
USD 364,727
|
|
|
2018-03-22 |
2018-03-20 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
17,060
-0.7%
20.61
USD 351,538
|
17,060
-0.7%
|
20.61
|
USD 351,538
|
|
|
2018-03-19 |
2018-03-19 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
13,439
-0.6%
20.57
USD 276,446
|
13,439
-0.6%
|
20.57
|
USD 276,446
|
|
|
2018-03-19 |
2018-03-16 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
6,926
-0.3%
20.51
USD 142,063
|
6,926
-0.3%
|
20.51
|
USD 142,063
|
|
|
2018-03-15 |
2018-03-15 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
11,751
-0.5%
20.64
USD 242,521
|
11,751
-0.5%
|
20.64
|
USD 242,521
|
|
|
2018-03-15 |
2018-03-14 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
200
-0.0%
20.77
USD 4,154
|
200
-0.0%
|
20.77
|
USD 4,154
|
|
|
2018-03-15 |
2018-03-13 |
S
Sale
|
CANAAN X L.P.
Large shareholder
|
1,204
-0.0%
20.84
USD 25,094
|
1,204
-0.0%
|
20.84
|
USD 25,094
|
|
|
2018-03-13 |
2018-03-12 |
PS
Planned sale
|
Liu David Y
Chief Scientific Officer
|
3,500
-18.9%
21.29
USD 74,500
|
3,500
-18.9%
|
21.29
|
USD 74,500
|
|
|
2018-03-02 |
2018-03-02 |
PS
Planned sale
|
Liu David Y
Chief Scientific Officer
|
875
-6.2%
20.00
USD 17,500
|
875
-6.2%
|
20.00
|
USD 17,500
|
|
|
2018-01-17 |
2018-01-16 |
PS
Planned sale
|
Liu David Y
Chief Scientific Officer
Officer
|
875
-18.6%
20.00
USD 17,500
|
875
-18.6%
|
20.00
|
USD 17,500
|
|
|
2017-12-27 |
2017-12-22 |
PS
Planned sale
|
Shames Richard S.
Chief Medical Officer
|
3,529
-100.0%
20.50
USD 72,345
|
3,529
-100.0%
|
20.50
|
USD 72,345
|
|
|
2017-12-21 |
2017-12-21 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
8,210
-4.1%
19.56
USD 160,570
|
8,210
-4.1%
|
19.56
|
USD 160,570
|
|
|
2017-12-20 |
2017-12-20 |
PS
Planned sale
|
PATEL DINESH V PH D
President and CEO
Executive Director
|
1,790
-0.9%
19.55
USD 34,987
|
1,790
-0.9%
|
19.55
|
USD 34,987
|
|
|
2017-12-20 |
2017-12-18 |
PS
Planned sale
|
O'Neil Thomas P.
Chief Financial Officer
|
8,000
-100.0%
20.00
USD 160,000
|
8,000
-100.0%
|
20.00
|
USD 160,000
|
|
|
2017-12-20 |
2017-12-18 |
PS
Planned sale
|
Liu David Y
Chief Scientific Officer
|
875
-18.6%
20.00
USD 17,500
|
875
-18.6%
|
20.00
|
USD 17,500
|
|
|
2017-12-01 |
2017-11-30 |
PS
Planned sale
|
Liu David Y
Chief Scientific Officer
|
875
-18.6%
20.00
USD 17,500
|
875
-18.6%
|
20.00
|
USD 17,500
|
|
|
2017-11-15 |
2017-11-13 |
PS
Planned sale
|
Liu David Y
Chief Scientific Officer
|
3,500
-47.8%
16.97
USD 59,381
|
3,500
-47.8%
|
16.97
|
USD 59,381
|
|
